175 related articles for article (PubMed ID: 26274488)
1. Effect of 6-8 weeks of oral ursodeoxycholic acid administration on serum concentrations of fasting and postprandial bile acids and biochemical analytes in healthy dogs.
Deitz KL; Makielski KM; Williams JM; Lin H; Morrison JA
Vet Clin Pathol; 2015 Sep; 44(3):431-6. PubMed ID: 26274488
[TBL] [Abstract][Full Text] [Related]
2. Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs.
Abraham LA; Charles JA; Holloway SA
Aust Vet J; 2004 Mar; 82(3):157-60. PubMed ID: 15088982
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of total serum bile acids concentration and bile acid profiles in healthy cats after oral administration of ursodeoxycholic acid.
Day DG; Meyer DJ; Johnson SE; Weisbrode SE; Thudium DT; Rhodes DC
Am J Vet Res; 1994 Oct; 55(10):1474-8. PubMed ID: 7998707
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Ursodeoxycholic Acid Therapy Does Not Alter Lithocholic Acid Levels in Patients with Cystic Fibrosis with Associated Liver Disease.
Colombo C; Crosignani A; Alicandro G; Zhang W; Biffi A; Motta V; Corti F; Setchell KDR
J Pediatr; 2016 Oct; 177():59-65.e1. PubMed ID: 27297203
[TBL] [Abstract][Full Text] [Related]
5. Determination of serum bile acids in fasting dogs with hepatobiliary disease.
Johnson SE; Rogers WA; Bonagura JD; Caldwell JH
Am J Vet Res; 1985 Oct; 46(10):2048-53. PubMed ID: 4062006
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of twelve-hour preprandial and two-hour postprandial serum bile acids concentrations for diagnosis of hepatobiliary disease in dogs.
Center SA; ManWarren T; Slater MR; Wilentz E
J Am Vet Med Assoc; 1991 Jul; 199(2):217-26. PubMed ID: 1890031
[TBL] [Abstract][Full Text] [Related]
7. Variations in total bile acid concentration in serum of dogs after a test meal.
Jensen AL
Zentralbl Veterinarmed A; 1991 May; 38(4):241-6. PubMed ID: 1907781
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of serum bile acid concentrations for the diagnosis of portosystemic venous anomalies in the dog and cat.
Center SA; Baldwin BH; de Lahunta A; Dietze AE; Tennant BC
J Am Vet Med Assoc; 1985 May; 186(10):1090-4. PubMed ID: 3997624
[TBL] [Abstract][Full Text] [Related]
9. Serum bile acid analysis in dogs with experimentally induced cholestatic jaundice.
Rutgers HC; Stradley RP; Johnson SE
Am J Vet Res; 1988 Mar; 49(3):317-20. PubMed ID: 3358542
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
Rust C; Sauter GH; Oswald M; Büttner J; Kullak-Ublick GA; Paumgartner G; Beuers U
Eur J Clin Invest; 2000 Feb; 30(2):135-9. PubMed ID: 10651838
[TBL] [Abstract][Full Text] [Related]
11. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
12. Bile acid metabolism, bacterial bowel flora and intestinal function following ileal pouch-anal anastomosis in dogs, with reference to the influence of administration of ursodeoxycholic acid.
Imamura M; Nakajima H; Takahashi H; Yamauchi H; Seo G
Tohoku J Exp Med; 2000 Feb; 190(2):103-17. PubMed ID: 10770619
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study.
McGlone ER; Malallah K; Cuenco J; Wewer Albrechtsen NJ; Holst JJ; Vincent RP; Ling C; Khan OA; Verma S; Ahmed AR; Walters JRF; Khoo B; Bloom SR; Tan TMM
Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E671-E679. PubMed ID: 33459181
[TBL] [Abstract][Full Text] [Related]
14. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of ursodeoxycholic acid withdrawal in patients with primary sclerosing cholangitis.
Wunsch E; Trottier J; Milkiewicz M; Raszeja-Wyszomirska J; Hirschfield GM; Barbier O; Milkiewicz P
Hepatology; 2014 Sep; 60(3):931-40. PubMed ID: 24519384
[TBL] [Abstract][Full Text] [Related]
16. Formation of iso-ursodeoxycholic acid during administration of ursodeoxycholic acid in man.
Beuers U; Fischer S; Spengler U; Paumgartner G
J Hepatol; 1991 Jul; 13(1):97-103. PubMed ID: 1918882
[TBL] [Abstract][Full Text] [Related]
17. Ursodeoxycholic acid and cholesterol induce enterohepatic cycling of bilirubin in rodents.
Méndez-Sánchez N; Brink MA; Paigen B; Carey MC
Gastroenterology; 1998 Sep; 115(3):722-32. PubMed ID: 9721170
[TBL] [Abstract][Full Text] [Related]
18. Effects of massive small bowel resection on metabolism of bile acids and vitamin D3 and gastrin release in dogs.
Imamura M; Yamauchi H
Tohoku J Exp Med; 1992 Nov; 168(3):515-28. PubMed ID: 1339002
[TBL] [Abstract][Full Text] [Related]
19. Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage.
Walker S; Rudolph G; Raedsch R; Stiehl A
Gastroenterology; 1992 Mar; 102(3):810-5. PubMed ID: 1537519
[TBL] [Abstract][Full Text] [Related]
20. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
